These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 8187322

  • 1. Steroid receptor binding and messenger RNA expression in fibroids from untreated and gonadotrophin-releasing hormone agonist pretreated women.
    Vollenhoven BJ, Pearce P, Herington AC, Healy DL.
    Clin Endocrinol (Oxf); 1994 Apr; 40(4):537-44. PubMed ID: 8187322
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Fibroid and myometrial steroid receptors in women treated with gonadotropin-releasing hormone agonist leuprolide acetate.
    Rein MS, Friedman AJ, Stuart JM, MacLaughlin DT.
    Fertil Steril; 1990 Jun; 53(6):1018-23. PubMed ID: 2112489
    [Abstract] [Full Text] [Related]

  • 4. Expression profiles of E/P receptors and fibrosis in GnRHa-treated and -untreated women with different uterine leiomyomas.
    Khan KN, Fujishita A, Koshiba A, Ogawa K, Mori T, Ogi H, Itoh K, Teramukai S, Kitawaki J.
    PLoS One; 2020 Jun; 15(11):e0242246. PubMed ID: 33186388
    [Abstract] [Full Text] [Related]

  • 5. The binding of steroids to myometrium and leiomyomata (fibroids) in women treated with the gonadotrophin-releasing hormone agonist Zoladex (ICI 118630).
    Lumsden MA, West CP, Hawkins RA, Bramley TA, Rumgay L, Baird DT.
    J Endocrinol; 1989 May; 121(2):389-96. PubMed ID: 2526844
    [Abstract] [Full Text] [Related]

  • 6. Rapid loss of oestrogen and progesterone receptors in human leiomyoma and myometrial explant cultures.
    Severino MF, Murray MJ, Brandon DD, Clinton GM, Burry KA, Novy MJ.
    Mol Hum Reprod; 1996 Nov; 2(11):823-8. PubMed ID: 9237221
    [Abstract] [Full Text] [Related]

  • 7. Different expression of estrogen receptors alpha and beta in human myometrium and leiomyoma during the proliferative phase of the menstrual cycle and after GnRHa treatment.
    Wang H, Wu X, Englund K, Masironi B, Eriksson H, Sahlin L.
    Gynecol Endocrinol; 2001 Dec; 15(6):443-52. PubMed ID: 11826769
    [Abstract] [Full Text] [Related]

  • 8. Total and unbound cytosolic estrogen and progesterone receptors in myometrium and fibroid after gonadotropin-releasing hormone agonist treatment.
    Fernández-Montolí ME, Díez-Gibert O, Samaniego JM, Balagueró L, Navarro MA.
    Fertil Steril; 1995 Mar; 63(3):522-7. PubMed ID: 7851581
    [Abstract] [Full Text] [Related]

  • 9. Preoperative medical therapy before surgery for uterine fibroids.
    Lethaby A, Puscasiu L, Vollenhoven B.
    Cochrane Database Syst Rev; 2017 Nov 15; 11(11):CD000547. PubMed ID: 29139105
    [Abstract] [Full Text] [Related]

  • 10. Expression of progesterone receptors A and B and insulin-like growth factor-I in human myometrium and fibroids after treatment with a gonadotropin-releasing hormone analogue.
    Wu X, Wang H, Englund K, Blanck A, Lindblom B, Sahlin L.
    Fertil Steril; 2002 Nov 15; 78(5):985-93. PubMed ID: 12413982
    [Abstract] [Full Text] [Related]

  • 11. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
    Lethaby A, Vollenhoven B, Sowter M.
    Cochrane Database Syst Rev; 2001 Nov 15; (2):CD000547. PubMed ID: 11405968
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of pre-operative gonadotrophin hormone releasing analogues for women with uterine fibroids undergoing hysterectomy or myomectomy: a systematic review.
    Lethaby A, Vollenhoven B, Sowter M.
    BJOG; 2002 Oct 15; 109(10):1097-108. PubMed ID: 12387461
    [Abstract] [Full Text] [Related]

  • 13. Decreased expression of mac25 mRNA in uterine leiomyomata compared with adjacent myometrium.
    Kim JG, Kim MH, Kim IS, Moon SY, Kang SB, Lee HP, Lee JY.
    Am J Reprod Immunol; 2000 Jan 15; 43(1):53-7. PubMed ID: 10698042
    [Abstract] [Full Text] [Related]

  • 14. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
    Lethaby A, Vollenhoven B, Sowter M.
    Cochrane Database Syst Rev; 2000 Jan 15; (2):CD000547. PubMed ID: 10796723
    [Abstract] [Full Text] [Related]

  • 15. Regression of uterine leiomyomata in response to the antiprogesterone RU 486.
    Murphy AA, Kettel LM, Morales AJ, Roberts VJ, Yen SS.
    J Clin Endocrinol Metab; 1993 Feb 15; 76(2):513-7. PubMed ID: 8432797
    [Abstract] [Full Text] [Related]

  • 16. [Clinical significance of analysis of estrogen and progesterone receptors in human uterine tissues].
    Maleeva A, Milkov V.
    Akush Ginekol (Mosk); 1991 May 15; (5):55-7. PubMed ID: 1897675
    [Abstract] [Full Text] [Related]

  • 17. Gene expression and tissue concentrations of IGF-I in human myometrium and fibroids under different hormonal conditions.
    Englund K, Lindblom B, Carlström K, Gustavsson I, Sjöblom P, Blanck A.
    Mol Hum Reprod; 2000 Oct 15; 6(10):915-20. PubMed ID: 11006320
    [Abstract] [Full Text] [Related]

  • 18. Tissue differences but limited sex steroid responsiveness of c-fos and c-jun in human fibroids and myometrium.
    Gustavsson I, Englund K, Faxén M, Sjöblom P, Lindblom B, Blanck A.
    Mol Hum Reprod; 2000 Jan 15; 6(1):55-9. PubMed ID: 10611261
    [Abstract] [Full Text] [Related]

  • 19. Oestrogen deficiency causes DNA damage in uterine leiomyoma cells: a possible mechanism for shrinkage of fibroids by GnRH agonists.
    Cheng YM, Chou CY, Huang SC, Lin HC.
    BJOG; 2001 Jan 15; 108(1):95-102. PubMed ID: 11213012
    [Abstract] [Full Text] [Related]

  • 20. An evidence-based approach to hormonal therapies for premenopausal women with fibroids.
    Lethaby AE, Vollenhoven BJ.
    Best Pract Res Clin Obstet Gynaecol; 2008 Apr 15; 22(2):307-31. PubMed ID: 17905660
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.